Sign in
4

Changes in Ownership

RESMED INC Filed Acc 0001127602-24-028139

Options or other derivatives

  • Director acquired 1,468 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
FARRELL PETER C Director 2024-11-25 Grant or award · ResMed Common Stock Options +1,468 $249.56 $366,354 1,468 D: show line 1 in the form
Loading xslF345X05/form4.xml…